15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.
- 2018-05-09
- Observational · n = 30
- Urologia 86(1)
- Andrey Zinovievich Vinarov
- Leonid Grigorievich Spivak
- Darina Vladimirovna Platonova
- Leonid Mikhailovich Rapoport
- Dmitry Olegovich Korolev
- PubMed: 29741118
- DOI: 10.1177/0391560318772466
- Moderate evidence
- Clinical
Changes in IPSS (International Prostatic Symptoms Scale) and QoL (Quality of life) scores and changes in Qmax, voided volume, residual urine volume, and prostate volume were evaluated during the study.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 320 mg once a day